Presentations

Documents

Order by : Name | Date | Hits | [ Descendent ]

The role of genetic assessments in Non-Alcoholic Fatty Liver Disease The role of genetic assessments in Non-Alcoholic Fatty Liver Disease

hot!
Date added: 03/13/2018
Date modified: 03/13/2018
Filesize: 6.91 MB
Downloads: 1564

Oral presentation given by UNEW at the 2nd International Workshop on NASH Biomarkers, Washington DC, USA, 5th - 6th May 2017

Regression of cirrhosis – a paradigm shift Regression of cirrhosis – a paradigm shift

hot!
Date added: 07/29/2019
Date modified: 07/29/2019
Filesize: 256 Bytes
Downloads: 1568

Presentation given by UMC at the Biannual Meeting of the Asian Pacific Association for the Study of the Liver (APASL), Manila, Philippines, 19th - 22nd February 2019

Hepatic lipotoxicity and mitochondrial dysfunction: impact of adipose tissue inflammation and... Hepatic lipotoxicity and mitochondrial dysfunction: impact of adipose tissue inflammation and...

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 256 Bytes
Downloads: 1581

"Hepatic lipotoxicity and mitochondrial dysfunction: impact of adipose tissue inflammation and insulin resistance"

Oral presentation given by CNR at the 51st European Society for Clinical Investigation (ESCI) conference, Genoa, Italy, 17th - 19th May 2017

Serum phosphatidylglycerols (PG) are correlated with human obesity, gut dysbiosis, and are induced.. Serum phosphatidylglycerols (PG) are correlated with human obesity, gut dysbiosis, and are induced..

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 256 Bytes
Downloads: 1588

"Serum phosphatidylglycerols (PG) are correlated with human obesity, gut dysbiosis, and are induced by endotoxin"

Poster presentation given by ICAN at the Keystone Symposium “Gastrointestinal Control of Metabolism”, Copenhagen, Denmark, 9th - 13th May 2017

Metabolomics approaches to study NAFLD Metabolomics approaches to study NAFLD

hot!
Date added: 06/02/2018
Date modified: 06/02/2018
Filesize: 256 Bytes
Downloads: 1612

Oral presentation given by ORU at the Federation of European Physiological Societies (FEPS) Congress, Vienna, Austria, 14th September 2017

NAFLD: Current & Future Therapeutic Approaches NAFLD: Current & Future Therapeutic Approaches

hot!
Date added: 06/02/2018
Date modified: 06/02/2018
Filesize: 256 Bytes
Downloads: 1614

Oral presentation given by UNEW at the BASL School of Hepatology, Newcastle upon Tyne, UK, 28th June 2017

Metabolic syndrome and NAFLD Metabolic syndrome and NAFLD

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 256 Bytes
Downloads: 1615

Oral presentation given by CNR at the Tuscan Hepatologists meeting, Italy, 10th - 11th May 2017

How common is NASH in your diabetes clinic? How common is NASH in your diabetes clinic?

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 256 Bytes
Downloads: 1636

Oral presentation given by UNITO at the 1st International Conference on Fatty Liver (ICFL), Seville, Spain, 1st - 3rd June 2017

Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin... Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin...

hot!
Date added: 03/13/2018
Date modified: 03/13/2018
Filesize: 256 Bytes
Downloads: 1649

"Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin Resistance and Liver Histology in Patients with NASH"

Oral presentation given by CNR at the European Group for the study of Insulin Resistance (EGIR) meeting, Dublin, Ireland, 4th - 6th May 2017

NAFLD in a patient with the metabolic syndrome NAFLD in a patient with the metabolic syndrome

hot!
Date added: 02/28/2018
Date modified: 02/28/2018
Filesize: 256 Bytes
Downloads: 1651

Invited oral presentation given by UHEL at the EASL International Liver Congress (ILC), Amsterdam, Netherlands, 19th - 23rd April 2017